Source: Virtual Congress 2021 – Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Olsson (Hannover, Germany). Low DLCO in pulmonary vascular diseases. Virtual Congress 2021 – Pulmonary vascular diseases

Member's Comments

No comment yet.

Related content which might interest you: Diffusing capacity for carbon monoxide (DLco) may predict appearance of pulmonary hypertension in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 More on idiopathic pulmonary arterial hypertension with a low diffusing capacity Source: Eur Respir J, 50 (2) 1700354; 10.1183/13993003.00354-2017 Year: 2017 Evaluation of FVC/DLCO ratio as a predictor for pulmonary hypertension in patients with interstitial lung diseases Source: International Congress 2017 – ILDs: clinical problems Year: 2017 The vascular bed in COPD: pulmonary hypertension and pulmonary vascular alterations Source: Eur Respir Rev 2014; 23: 350-355 Year: 2014 Pulmonary veno-occlusive disease Source: Eur Respir J 2009; 33: 189-200 Year: 2009 Updates in pulmonary hypertension and other pulmonary vascular diseases Source: Breathe, 15 (3) 241; 10.1183/20734735.0187-2019 Year: 2019 Pulmonary hypertension in interstitial lung diseases Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009 Pulmonary vascular and cardiac impairment in interstitial lung disease Source: Eur Respir Rev 2017; 26: 160128 Year: 2017 Patterns of cardiopulmonary response to exercise in lung diseases Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-49-5, page=69 Year: 2007 Pulmonary vascular changes in COPD and idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2006 - Clinical physiology Year: 2006 Treatment of pulmonary hypertension in chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=313 Year: 2006 Pulmonary vascular diseases Source: ERS Skills Course 2016 Year: 2016 Pulmonary vascular diseases Source: ERS Course 2015 Year: 2015 Relation between pulmonary arterial remodeling and parenchymal disease in severe COPD and interstitial lung disease patients Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 CPET in pulmonary vascular disease Source: ERS Skills course - Clinical exercise testing: advanced Year: 2018 Pulmonary hypertension in different interstitial lung diseases Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012 Arterial blood gases during exercise in chronic obstructive pulmonary disease with and without pulmonary hypertension Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011 Acute hyperoxic challenge improves haemodynamics & Pulmonary vascular stiffness in interstitial lung disease-associated pulmonary hypertension Source: International Congress 2016 – Connective tissue disorders Year: 2016 Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity Source: Eur Respir J 2005; 26: 586-593 Year: 2005 Pulmonary hypertension and endothelial dysfunction in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 605s Year: 2007